The present pilot study in rats was designed to evaluate the potential of a single intravenous bolus of an investigational BK channel antagonist in clinical development (ENA-001) to mitigate the acute respiratory depression induced by prior intravenous bolus infusion of an XFC to rats. This evidence concerns the gene KCNMA1 and respiratory depression.